About ULB Erasme
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Ipsen
1
Sumitomo Pharma Oncology, Inc.
1
University Hospital, Lille
1
Clinical Trials at ULB Erasme
During the past decade, ULB Erasme conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
2006-11-01
2007-10-01
Terminated
100
Validation of the Procedure of Early Liver Transplantation in Alcoholic Hepatitis Resisting to Medical Treatment
2012-12-05
2019-12-05
Completed
284
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma
2016-12-01
2020-03-01
Completed
1,134
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "ULB Erasme"
#1 collaborator was "Ministry of Health, France" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at ULB Erasme
According to Clinical.Site data, the most researched conditions in "ULB Erasme" are
"Alcoholic Cirrhosis" (1 trials), "Alcoholic Hepatitis" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "ULB Erasme" in a lesser frequency.
Clinical Trials Intervention Types at ULB Erasme
Most popular intervention types in "ULB Erasme" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (1 trials), "Liver transplantation" (1 trials), "Nab-paclitaxel" (1 trials), "Napabucasin" (1 trials) and "Triptorelin (Decapeptyl®) - Treatment 8 months (pivotal study) followed by a treatment extension of 8 months (extension study)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ULB Erasme
The vast majority of trials in "ULB Erasme" are
2 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at ULB Erasme
Currently, there are NaN active trials in "ULB Erasme".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in ULB Erasme,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ULB Erasme, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".